Patricia H. Warne

8.7k total citations · 4 hit papers
30 papers, 7.3k citations indexed

About

Patricia H. Warne is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Patricia H. Warne has authored 30 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Patricia H. Warne's work include Protein Kinase Regulation and GTPase Signaling (12 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and Cell death mechanisms and regulation (8 papers). Patricia H. Warne is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and Cell death mechanisms and regulation (8 papers). Patricia H. Warne collaborates with scholars based in United Kingdom, United States and France. Patricia H. Warne's co-authors include Julian Downward, Pablo Rodriguez‐Viciana, Ritu Dhand, Michael Fry, Michael D. Waterfield, Ivan Gout, Bart Vanhaesebroeck, Jonathan D. Graves, Doreen A. Cantrell and Sydonia Rayter and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Patricia H. Warne

30 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphatidylinositol-3-OH kinase direct target of Ras

1994 1.6k citations Pablo Rodriguez‐Viciana, Patricia H. Warne et al. Nature profile →
Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras

1997 930 citations Pablo Rodriguez‐Viciana, Patricia H. Warne et al. Cell profile →
Stimulation of p21ras upon T-cell activation

1990 794 citations Julian Downward, Jonathan D. Graves et al. Nature profile →
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro

1993 634 citations Patricia H. Warne, Julian Downward et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia H. Warne United Kingdom	25	5.8k	1.8k	1.2k	938	705	30	7.3k
Pablo Rodriguez‐Viciana United States	24	5.2k 0.9×	1.5k 0.8×	1.1k 0.9×	731 0.8×	572 0.8×	31	6.3k
David T. Weaver United States	49	6.5k 1.1×	2.6k 1.5×	747 0.6×	1.4k 1.4×	1.3k 1.9×	150	9.0k
Sean E. Egan Canada	40	4.7k 0.8×	1.9k 1.0×	839 0.7×	874 0.9×	1.0k 1.4×	85	6.6k
Jaime A. Escobedo United States	26	5.4k 0.9×	1.2k 0.7×	998 0.8×	771 0.8×	814 1.2×	38	7.0k
Andreas Batzer United States	24	5.7k 1.0×	1.7k 1.0×	976 0.8×	1.1k 1.2×	414 0.6×	26	7.4k
Kurt R. Auger United States	22	4.1k 0.7×	1.3k 0.7×	1.0k 0.8×	661 0.7×	405 0.6×	33	5.4k
Jill M. Lahti United States	46	4.3k 0.7×	1.8k 1.0×	877 0.7×	889 0.9×	926 1.3×	88	5.9k
Alessandra Eva Italy	35	3.5k 0.6×	1.0k 0.6×	1.1k 0.9×	1.1k 1.2×	744 1.1×	111	5.5k
Catrin Pritchard United Kingdom	36	3.9k 0.7×	1.9k 1.0×	845 0.7×	558 0.6×	594 0.8×	88	5.9k
Silvia Soddu Italy	44	3.8k 0.6×	2.6k 1.4×	679 0.6×	656 0.7×	887 1.3×	140	5.5k

Countries citing papers authored by Patricia H. Warne

Since Specialization

Citations

This map shows the geographic impact of Patricia H. Warne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia H. Warne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia H. Warne more than expected).

Fields of papers citing papers by Patricia H. Warne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia H. Warne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia H. Warne. The network helps show where Patricia H. Warne may publish in the future.

Co-authorship network of co-authors of Patricia H. Warne

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia H. Warne. A scholar is included among the top collaborators of Patricia H. Warne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia H. Warne. Patricia H. Warne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruin, Elza C. de, Catherine Cowell, Patricia H. Warne, et al.. (2014). Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer. Cancer Discovery. 4(5). 606–619. 154 indexed citations

Weigelt, Britta, Patricia H. Warne, Maryou Lambros, Jorge S. Reis‐Filho, & Julian Downward. (2013). PI3K Pathway Dependencies in Endometrioid Endometrial Cancer Cell Lines. Clinical Cancer Research. 19(13). 3533–3544. 107 indexed citations

Steckel, Michael, Míriam Molina‐Arcas, Britta Weigelt, et al.. (2012). Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell Research. 22(8). 1227–1245. 128 indexed citations

Weigelt, Britta, Patricia H. Warne, & Julian Downward. (2011). PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs. Oncogene. 30(29). 3222–3233. 143 indexed citations

Swanton, Charles, Michela Marani, Olivier E. Pardo, et al.. (2007). Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs. Cancer Cell. 11(6). 498–512. 307 indexed citations

Michl, Patrick, Antoine R. Ramjaun, Olivier E. Pardo, et al.. (2005). CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness. Cancer Cell. 7(6). 521–532. 135 indexed citations

Jansson, Anna, Lubna Yasmin, Patricia H. Warne, et al.. (2005). Exoenzyme S of Pseudomonas aeruginosa is not able to induce apoptosis when cells express activated proteins, such as Ras or protein kinase B/Akt. Cellular Microbiology. 8(5). 815–822. 15 indexed citations

Schulze, Almut, Barbara Nicke, Patricia H. Warne, Simon R. Tomlinson, & Julian Downward. (2004). The Transcriptional Response to Raf Activation Is Almost Completely Dependent on Mitogen-activated Protein Kinase Kinase Activity and Shows a Major Autocrine Component. Molecular Biology of the Cell. 15(7). 3450–3463. 55 indexed citations

Nicolás, Francisco José, Kerstin Lehmann, Patricia H. Warne, Caroline S. Hill, & Julian Downward. (2003). Epithelial to Mesenchymal Transition in Madin-Darby Canine Kidney Cells Is Accompanied by Down-regulation of Smad3 Expression, Leading to Resistance to Transforming Growth Factor-β-induced Growth Arrest. Journal of Biological Chemistry. 278(5). 3251–3256. 62 indexed citations

10.

Douville, Elizabeth, Patricia H. Warne, Catherine Papin, et al.. (1998). Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Current Biology. 8(1). 46–55. 132 indexed citations

11.

Rodriguez‐Viciana, Pablo, Patricia H. Warne, Asim Khwaja, et al.. (1997). Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras. Cell. 89(3). 457–467. 930 indexed citations breakdown →

12.

Marte, Barbara, Pablo Rodriguez‐Viciana, Stefan Wennström, Patricia H. Warne, & Julian Downward. (1997). R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Current Biology. 7(1). 63–71. 193 indexed citations

13.

Rodriguez‐Viciana, Pablo, Barbara Marte, Patricia H. Warne, Julian Downward, & Christopher J. Marshall. (1996). Phosphatidylinositol 3’ kinase: one of the effectors of Ras. Philosophical Transactions of the Royal Society B Biological Sciences. 351(1336). 225–232. 65 indexed citations

14.

Rodriguez‐Viciana, Pablo, Patricia H. Warne, Bart Vanhaesebroeck, M.D. Waterfield, & Julian Downward. (1996). Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.. The EMBO Journal. 15(10). 2442–2451. 479 indexed citations

15.

Rodriguez‐Viciana, Pablo, Patricia H. Warne, Ritu Dhand, et al.. (1994). Phosphatidylinositol-3-OH kinase direct target of Ras. Nature. 370(6490). 527–532. 1640 indexed citations breakdown →

16.

Graves, Jonathan D., Julian Downward, Sydonia Rayter, et al.. (1991). CD2 antigen mediated activation of the guanine nucleotide binding proteins p21ras in human T lymphocytes. The Journal of Immunology. 146(11). 3709–3712. 54 indexed citations

17.

Downward, Julian, Jonathan D. Graves, Patricia H. Warne, Sydonia Rayter, & Doreen A. Cantrell. (1990). Stimulation of p21ras upon T-cell activation. Nature. 346(6286). 719–723. 794 indexed citations breakdown →

18.

Durbin, H., et al.. (1988). Production of monoclonal antibodies to placental alkaline phosphatase: Preliminary characterisation includes identification of one antibody reactive with routinely fixed histological preparations. International Journal of Cancer. 41(S2). 50–58. 10 indexed citations

19.

Tucker, D. F., R A Knight, & Patricia H. Warne. (1983). Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology. Clinical & Experimental Metastasis. 1(3). 275–287. 2 indexed citations

20.

Tucker, D. F., R A Knight, & Patricia H. Warne. (1983). Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part l. Biology of tumour regression and recurrence. Clinical & Experimental Metastasis. 1(3). 261–273. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact